Skip to main content
HR 3794 118th Congress House Health Advanced technology and technological innovations Congressional oversight Emergency planning and evacuation Health technology, devices, supplies Infectious and parasitic diseases Public contracts and procurement Research administration and funding Research and development Technology transfer and commercialization

FLASH Act of 2023

Introduced: June 5, 2023 Introduced by: Garcia, Robert Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 22, 2023
Sponsor introductory remarks on measure. (CR H3077)
Jun 9, 2023
Referred to the Subcommittee on Health.
Jun 5, 2023
Referred to the House Committee on Energy and Commerce.
Jun 5, 2023
Introduced in House
 Plain-English summary Congressional Research Service

Fast-track Logistics for Acquiring Supplies in a Hurry Act of 2023 or the FLASH Act of 2023

This bill expands federal contracting and other authorities to support the development and acquisition of products and supplies that are necessary for national public health and health security.

Specifically, the Department of Health and Human Services (HHS) may use noncompetitive procedures to procure medical countermeasures (e.g., vaccines), chemical materials and reagents, manufacturing supplies, and similar items that are needed to develop products for national public health and health security.

Additionally, HHS may acquire, subject to dollar limits and other conditions, innovative commercial products and services by soliciting proposals and selecting proposals through peer review.

Further, the bill expands the activities of the Biomedical Advanced Research and Development Authority (BARDA) to include supporting the design and development of prototypes for products to diagnose, mitigate, prevent, treat, or otherwise respond to biological, chemical, radiological, or nuclear threats, including pandemics or epidemics. If BARDA enters an initial transaction to design or develop such a test or prototype using competitive procedures, BARDA may use noncompetitive procedures for a follow-on transaction to produce the test or prototype.

What's happening now June 22, 2023

Sponsor introductory remarks on measure. (CR H3077)

 Committees of jurisdiction 2